Dr Gil Morgan from OncoAlert gives his insights on what to look out for from Day 2 of ESMO 2021.
Dr morgan mentions results from trials including VESPER, GIM4 and CheckMate 743.
He also reports that the results from the OncoAlert poster on attitudes towards the use of SBRT in oligometastatic breast cancer are out.
You can watch Dr Morgan's previous roundup here
Follow Dr Morgan on twitter: @OncoAlert
Follow ecancer on twitter: @ecancer
Search and follow #OncoAlertTopTweet to stay up to date.